Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: Patient selection and associated treatment patterns

Academic Emergency Medicine

Volumn 12, Issue 5, 2005, Pages 431-438

  Hoekstra, James W ^a   Roe, Matthew T ^b   Peterson, Eric D ^b   Menon, Venu ^c   Mulgund, Jyotsna ^b   Pollack, Charles V ^d   Miller, Chadwick ^a   Palabrica, Theresa ^e   Harrington, Robert A ^b   Ohman, E Magnus ^c   Gibler, W Brian ^f  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e MILLENNIUM PHARMACEUTICALS INC   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Glycoprotein IIb IIIa inhibitors; Guidelines recommended therapies; Non ST segment elevation acute coronary syndrome

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY CARE UNIT; DATA ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX ROLE; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; THORAX PAIN;

EID: 20944442420     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2004.11.029     Document Type: Article

References (17)

1. PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy N Engl J Med 339 1998 436 443
2. The PRISM-PLUS Investigators Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms N Engl J Med 338 1998 1488 1497
3. M.L. Simoons, and GUSTO IV-ACS Investigators Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial Lancet 357 2001 1915 1924
4. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Group N Engl J Med 337 1997 447 452
5. E.M. Antman, C.H. McCabe, and E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction (TIMI) 11B trial Circulation 100 1999 1593 1601
6. D.F. Kong, V. Hasselblad, and R.A. Harrington Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions Am J Cardiol 92 2003 651 655
7. E.M. Antman, M. Cohen, and P.J. Bernink The TIMI risk score for unstable angina/non-ST elevation MI: a method of prognostication and therapeutic decision making JAMA 284 2000 835 842
8. E.M. Ohman, P.W. Armstrong, and R.H. Christenson Cardiac troponin T levels for risk stratification in acute myocardial ischemia N Engl J Med 335 1996 1333 1341
9. E.M. Antman, M.J. Tanasijevic, and B. Thompson Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes N Engl J Med 335 1996 1342 1349
10. E. Boersma, K.S. Pieper, and E.W. Steyerberg Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients Circulation 101 2000 2557 2567
11. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Unstable Angina) Circulation 102 2000 1193 1209 2002 update posted at http://www.acc.org on Mar 15, 2002
12. C.V. Pollack Jr., M.T. Roe, and E.D. Peterson 2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice Ann Emerg Med 41 2003 355 369
13. E. Boersma, R.A. Harrington, and D.J. Moliterno Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials Lancet 359 2002 189 198
14. W.J. Rogers, J.G. Canto, and C.T. Lambrew Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 36 2000 2056 2063
15. E.D. Peterson, C.V. Pollack Jr., and M.T. Roe Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4 J Am Coll Cardiol 42 2003 45 53
16. J. Hoekstra, C. Pollack, and M. Roe Improving the care of patients with acute coronary syndromes in the ED: the CRUSADE initiative Acad Emerg Med 9 2002 1146 1155
17. K.-Y. Liang, and S.L. Zeger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22